Aavantibio

Developer of gene transfer therapies for neuromuscular disease

placeGainesville, Florida, United States calendar_todayFounded 2017 groups57 employees language aavantibio.com

Investor mix

6 investors on record; lead investors include Muscular Dystrophy Association, GoFar, Perceptive Advisors, Bain Capital.

Investor typeCountShare
Venture capital117%
Private equity117%
Other / undisclosed467%
Coming soon